BPC-157 lacks human clinical data despite promising preclinical results
If you take antidepressants, mood stabilizers, antipsychotics, or anti-anxiety medicines, keep your prescriber informed before and during GLP-1 therapy
For a detailed exploration of the cognitive benefits observed in preclinical studies, our Semax peptide benefits guide covers the science-backed literature
In addition, death from any cause occurred in 1.4% of participants in the oral semaglutide arm and 2.8% in the placebo group, a hazard ratio of 0.51 (95% CI 0.310.84), thus raising the possibility that oral semaglutide might in fact reduce mortality risk
While this leads to weight loss, it doesn't automatically improve cardiovascular fitness, maintain muscle mass, or build strength
Long-term effects of ad libitum low-fat, high-carbohydrate diets on body weight and serum lipids in overweight subjects with metabolic syndrome